Trial Profile
A PROSPECTIVE, RANDOMIZED COMPARATIVE TRIAL OF MIZORIBINE VERSUS MYCOPHENOLATE MOFETIL IN COMBINATION THERAPY WITH TACROLIMUS AND BASILIXIMAB FOR LIVING DONOR RENAL TRANSPLANTATION.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 23 Jul 2015
Price :
$35
*
At a glance
- Drugs Mizoribine (Primary) ; Mycophenolate mofetil (Primary) ; Basiliximab; Steroids; Tacrolimus
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 08 Dec 2012 New trial record